Human papilloma virus vaccination: impact and recommendations across the world (original) (raw)

Global human papilloma virus vaccine implementation: An update

Govindakarnavar Arunkumar

Journal of Obstetrics and Gynaecology Research, 2018

View PDFchevron_right

Vaccination to prevent human papillomavirus infections: From promise to practice

Paul Bloem

PLOS Medicine, 2017

View PDFchevron_right

Human Papillomavirus Vaccination and Its Associated Factors Among Female Adolescents (Aged 9-14 Years) Attending Kajjansi Health Center IV in Wakiso District: A Cross-Sectional Study

Jane Frank Nalubega

2024

View PDFchevron_right

Human Papillomavirus Vaccination: Expected Impacts and Unresolved Issues

Gary Freed

The Journal of Pediatrics, 2008

View PDFchevron_right

Human papillomavirus vaccine: A boon or curse

Inderjeet singh

Human Vaccines & Immunotherapeutics, 2014

View PDFchevron_right

Improving human papilloma virus vaccination rates in developing economies.

Patrick A Palmieri

2014

View PDFchevron_right

Contemporary studies about vaccination against human papillomavirus

Juliana Cogo

Research, Society and Development

View PDFchevron_right

Primary prophylactic human papillomavirus vaccination programs: future perspective on global impact

Julia Brotherton

Expert Review of Anti-infective Therapy, 2011

View PDFchevron_right

Ten years of anti-HPV vaccinations: what do we know?

Jan Kotarski

Menopausal Review, 2016

View PDFchevron_right

Cervical cancer: problem solved? Vaccinating girls against human papillomavirus

Emma Crosbie

BJOG: An International Journal of Obstetrics & Gynaecology, 2010

View PDFchevron_right

The role of the human papillomavirus (HPV) vaccine in developing countries

Max Kling

International Journal of Dermatology, 2010

View PDFchevron_right

Human papilloma virus vaccination for control of cervical cancer: a challenge for developing countries

ISAAC ADEWOLE

African Journal of Reproductive Health, 2011

View PDFchevron_right

Voluntary School-Based Human Papillomavirus Vaccination: An Efficient and Acceptable Model for Achieving High Vaccine Coverage in Adolescents

Spring Cooper

Journal of Adolescent Health, 2010

View PDFchevron_right

Prophylactic human papillomavirus vaccination update

Alison Fiander

The Obstetrician & Gynaecologist, 2009

View PDFchevron_right

Fall in Human Papillomavirus Prevalence Following a National Vaccination Program

Suzanne Garland

Journal of Infectious Diseases, 2012

View PDFchevron_right

Substantial Decline in Vaccine-Type Human Papillomavirus (HPV) Among Vaccinated Young Women During the First 8 Years After HPV Vaccine Introduction in a Community

Darron Brown

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2016

View PDFchevron_right

Human Papillomavirus Vaccine Introduction – The First Five Years

Susan Wang

Vaccine, 2012

View PDFchevron_right

Effectiveness of human papillomavirus vaccine against incident and persistent infections among young girls: Results from a longitudinal Dutch cohort study

Audrey King

Vaccine, 2015

View PDFchevron_right

Reduction in Human Papillomavirus (HPV) Prevalence Among Young Women Following HPV Vaccine Introduction in the United States, National Health and Nutrition Examination Surveys, 2003-2010

Martin Steinau

Journal of Infectious Diseases, 2013

View PDFchevron_right

Current global status & impact of human papillomavirus vaccination: Implications for India

Partha basu

Indian Journal of Medical Research, 2016

View PDFchevron_right

Human Papillomavirus (HPV): Making the case for "Immunisation for All

Saman Warnakulasuriya

Oral diseases, 2016

View PDFchevron_right

Risk of cervical HPV infection and prevalence of vaccine-type and other high-risk HPV types among sexually active teens and young women (13–26 years) enrolled in the VALHIDATE study

Irene Cetin

Human Vaccines & Immunotherapeutics, 2014

View PDFchevron_right

Universal HPV Vaccination – a Global Prerogative

Gilla Shapiro

International Journal of Mens Social and Community Health

View PDFchevron_right

Prevalence and predictors of human papillomavirus vaccination in adolescent girls

Marie Bangura

Journal of the American Pharmacists Association, 2012

View PDFchevron_right

Prevalence of Human Papillomavirus Among Females After Vaccine Introduction—National Health and Nutrition Examination Survey, United States, 2003–2014

Martin Steinau

The Journal of Infectious Diseases

View PDFchevron_right

Aspects of Prophylactic Vaccination against Cervical Cancer and Other Human Papillomavirus-Related Cancers in Developing Countries

Johannes Lehtinen

Infectious Diseases in Obstetrics and Gynecology, 2011

View PDFchevron_right

Human papillomavirus vaccination in the resourced and resource-constrained world

siti omar

Best Practice & Research Clinical Obstetrics & Gynaecology, 2011

View PDFchevron_right

Human papillomavirus vaccination coverage among adolescents, 2007-2013, and postlicensure vaccine safety monitoring, 2006-2014--United States

Mary Barton

MMWR. Morbidity and mortality weekly report, 2014

View PDFchevron_right

Vaccine Strategies against Human Papillomavirus: A Discussion Focused on Developing Countries

Antonio Freitas

Journal of Clinical & Cellular Immunology, 2012

View PDFchevron_right